September 13, 2018

Tosk, Inc. Receives Additional $2 million NCI Grant for Promising KRAS Project

MOUNTAIN VIEW, CALIFORNIA, USA, September 13, 2018 /EINPresswire.com/ — NATIONAL CANCER INSTITUTE RENEWS GRANT FOR TOSK, INC’S, PROMISING CANCER KRAS PROGRAM “Tosk’s scientists are focused on […]
July 15, 2017

Tosk Reports Initiation of POC Human Studies

MOUNTAIN VIEW, CA, JULY 19, 2017 Tosk, Inc. reported today the completion of Phase 1 safety trials and the initiation of POC studies in human cancer […]
December 11, 2018

Tosk Presents Jointly on KRAS Project at Research Meeting in San Diego

Mountain View, CA, December 11, 2018   ̶  Privately held biotechnology company, Tosk, Inc., announced today a joint presentation with the US National Cancer Institute (NCI) […]